Orchid unit clears USFDA inspection

R. Yegyanarayanan Coimbatore | Updated on March 12, 2018

Chennai-based pharma company Orchid Chemicals & Pharmaceuticals has said that its Cephalosporin API manufacturing complex in Alathur, Chennai, has cleared the recent USFDA inspection.

“We have been manufacturing Cephalosporin API since 1994. This is a periodic inspection done every few years. Manufacturing API is a stringent process as it related to chemicals and dictated by quality,” said a company spokesperson.

The Alathur facility manufactures a range of oral and sterile Cephalosporin APIs (it is an antibiotic used to treat infection and inflammation) and caters to developed markets such as the US, Europe and Japan.

“This successful inspection would help the continuing supply of the niche APIs manufactured by Orchid in this location to the developed markets,” said the company release.

Published on June 22, 2011

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

This article is closed for comments.
Please Email the Editor